National and Kapodistrian University of Athens
Σύγχρονη ιστολογική προσέγγιση του αδενοκαρκινώματος του προστάτη αδένα
Abstract
dc:descriptionProstate cancer is currently recognized as the second most common cause of cancer- related mortality in men, following lung cancer, according to the Cancer Statistics 2022 report. Its global incidence exhibits substantial geographical variability, with significantly higher rates observed in developed countries compared to developing regions. This disparity is attributed to multiple factors, including genetic susceptibility, dietary and lifestyle patterns, and disparities in access to diagnostic and therapeutic healthcare services. Despite ongoing research efforts, our understanding of the natural history of prostate cancer remains incomplete. In particular, the molecular events that precede disease onset and those that follow androgen deprivation therapy are not yet fully elucidated, thereby limiting the development of effective, targeted treatments. Nonetheless, recent advancements in molecular biology and the widespread adoption of high-throughput sequencing technologies have considerably advanced our knowledge of the disease’s underlying mechanisms, setting the foundation for the implementation of precision medicine in the management of prostate cancer.The aim of this thesis is to investigate the immunohistochemical expression of the proteins p300 and TMPRSS2 and their association with key histopathological parameters, such as the Gleason score and tumor stage. This study aims to explore the prognostic and predictive significance of the two proteins in question, with the intent of shedding light on the underlying molecular mechanisms of the disease and advancing the application of personalized treatment approaches.A total of 87 formalin-fixed, paraffin-embedded (FFPE) radical prostatectomy specimens were included in the study. Of these, 55 cases met the predefined inclusion criteria for TMPRSS2 analysis, and 58 for p300 analysis. The samples were obtained from male patients aged 51 to 81 years who underwent radical prostatectomy between 2018 and 2022.The sample encompassed the full spectrum of prostate adenocarcinoma (PRAD) differentiation, with 51.72% of cases classified as low-grade tumors (Gleason pattern 3) and 48.28% as high-grade tumors (patterns 4 and 5). Gleason scores ranged from 6 to 10, with the most frequent being 3+4 and 4+3. Cases were stratified into two differentiation groups—low-grade and high-grade. Tissue processing and stain evaluation were performed using standardized protocols (H&E staining, pTNM classification, WHO guidelines) by two independent pathologists. Complete interobserver agreement was achieved (H-score), and the findings were correlated with Gleason grading and tumor aggressiveness.TMPRSS2 expression was detected in all prostate cancer specimens (100%). In benign tissues, the protein was mainly localized to the luminal surface of prostatic gland cells, whereas in malignant tissues, it exhibited a cytoplasmic distribution. This shift in subcellular localization correlated with increased histological aggressiveness, particularly in high-grade tumors. While these observations suggest a relationship between TMPRSS2 localization and tumor grade, they reflect general trends rather than statistically significant findings. Quantitative analysis further revealed a gradual increase in TMPRSS2 expression with rising Gleason patterns. Specifically, the mean H-score was 126.7 for Gleason pattern 3, increased to 141.1 in pattern 4, and peaked at180.0 in pattern 5. This progressive elevation in staining intensity may indicate an association between higher TMPRSS2 expression and more aggressive, poorly differentiated tumors, although intergroup variability limited statistical significance.p300 immunopositivity was observed in all evaluated specimens (100%), with significant differences in expression between benign and malignant prostate tissues. Cancerous tissues exhibited increased staining intensity and a higher proportion of positively stained cells, especially in poorly differentiated, high-grade tumors. Notably, cribriform structures and Gleason pattern 5 areas demonstrated the most intense staining pattern. A progressive increase in p300 expression was observed across Gleason patterns, with the lowest expression in Gleason pattern 3 (mean H-score: 160.4), a moderate increase in pattern 4 (mean H-score: 180.9), and the highest expression in pattern 5 (mean H-score: 198.3). This gradual upregulation of p300 correlated significantly with decreasing tumor differentiation and increasing malignancy. Statistical analysis confirmed the association between increased p300 expression and tumor grade (χ² test, p = 0.010; Fisher’s Exact Test, p = 0.011), supporting its potential role as a prognostic biomarker in prostate cancer.In conclusion, the expression patterns of TMPRSS2 and p300 appear to be closely linked to the aggressiveness of prostate cancer, indicating their potential utility as prognostic biomarkers and therapeutic targets. Further validation through large-scale,well-designed studies is necessary to establish definitive evidence and support their translation into clinical practice.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gioukaki, Charitomeni
- Γιουκάκη, Χαριτομένη
Subjects
dc:subject × 18- P300
- TMPRSS2
- Καρκίνος προστάτη
- Μοριακή παθολογία
- Προγνωστικός βιοδείκτης
- Prostate cancer
- Molecular pathology
- Prognostic biomarkers
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Βασική Ιατρική
- Παθολογοανατομία
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
- Basic Medicine
- Pathology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59803